Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)
China
· Delayed Price · Currency is CNY 11.19
+0.21 (1.91%)
At close: Mar 10, 2026
SHE:300016 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 6,299 | 3,050 | 3,503 | 3,208 | 4,523 | 4,727 | Upgrade
|
| Market Cap Growth | 89.12% | -12.92% | 9.20% | -29.09% | -4.32% | 6.30% | Upgrade
|
| Enterprise Value | 6,252 | 3,388 | 3,635 | 3,239 | 4,391 | 4,697 | Upgrade
|
| Last Close Price | 11.19 | 6.15 | 7.07 | 6.40 | 8.92 | 9.23 | Upgrade
|
| PE Ratio | 156.56 | 223.42 | - | 284.26 | 36.04 | 27.06 | Upgrade
|
| Forward PE | - | 19.22 | 19.22 | 19.22 | 19.22 | 19.22 | Upgrade
|
| PS Ratio | 5.59 | 3.10 | 3.93 | 4.19 | 5.26 | 5.71 | Upgrade
|
| PB Ratio | 2.66 | 1.67 | 1.96 | 1.67 | 2.17 | 2.50 | Upgrade
|
| P/TBV Ratio | 3.13 | 2.09 | 2.30 | 1.98 | 2.71 | 3.05 | Upgrade
|
| P/FCF Ratio | - | 49.49 | - | 128.15 | - | 1211.38 | Upgrade
|
| P/OCF Ratio | 40.72 | 18.71 | 59.91 | 25.10 | 41.60 | 26.86 | Upgrade
|
| EV/Sales Ratio | 5.55 | 3.45 | 4.08 | 4.23 | 5.11 | 5.68 | Upgrade
|
| EV/EBITDA Ratio | 40.25 | 23.62 | 64.58 | 46.41 | 23.08 | 26.09 | Upgrade
|
| EV/EBIT Ratio | 114.70 | 63.64 | - | - | 34.43 | 34.20 | Upgrade
|
| EV/FCF Ratio | -153.70 | 54.97 | - | 129.42 | - | 1203.59 | Upgrade
|
| Debt / Equity Ratio | 0.21 | 0.44 | 0.44 | 0.34 | 0.28 | 0.37 | Upgrade
|
| Debt / EBITDA Ratio | 3.16 | 5.41 | 13.30 | 8.92 | 3.02 | 3.91 | Upgrade
|
| Debt / FCF Ratio | - | 12.94 | - | 25.84 | - | 180.17 | Upgrade
|
| Net Debt / Equity Ratio | -0.09 | 0.10 | 0.02 | -0.06 | -0.15 | -0.16 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.35 | 1.32 | 0.75 | -1.72 | -1.68 | -1.72 | Upgrade
|
| Net Debt / FCF Ratio | 5.03 | 3.07 | -0.49 | -4.79 | 8.18 | -79.60 | Upgrade
|
| Asset Turnover | 0.36 | 0.34 | 0.32 | 0.27 | 0.30 | 0.37 | Upgrade
|
| Inventory Turnover | 1.83 | 1.73 | 1.86 | 1.39 | 1.79 | 2.34 | Upgrade
|
| Quick Ratio | 1.53 | 1.74 | 2.63 | 2.93 | 3.65 | 3.55 | Upgrade
|
| Current Ratio | 2.22 | 2.57 | 3.33 | 3.89 | 4.57 | 3.93 | Upgrade
|
| Return on Equity (ROE) | 0.98% | 0.01% | -4.49% | -0.23% | 5.54% | 9.21% | Upgrade
|
| Return on Assets (ROA) | 1.09% | 1.15% | -0.55% | -0.11% | 2.77% | 3.84% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.39% | 2.77% | -1.38% | -0.29% | 6.87% | 6.98% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.10% | 2.10% | -1.00% | -0.20% | 4.90% | 5.50% | Upgrade
|
| Earnings Yield | 0.53% | 0.45% | -2.05% | 0.35% | 2.77% | 3.70% | Upgrade
|
| FCF Yield | -0.65% | 2.02% | -2.46% | 0.78% | -0.86% | 0.08% | Upgrade
|
| Dividend Yield | 0.46% | 0.81% | - | 1.09% | 0.78% | 0.65% | Upgrade
|
| Payout Ratio | 137.72% | 153.09% | - | 465.63% | 35.77% | 23.77% | Upgrade
|
| Buyback Yield / Dilution | 3.04% | 4.88% | 15.21% | -16.87% | 0.52% | 0.80% | Upgrade
|
| Total Shareholder Return | 3.50% | 5.69% | 15.21% | -15.78% | 1.31% | 1.45% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.